Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cardio

Date Submitted: Apr 11, 2023
Date Accepted: Jun 21, 2023

The final, peer-reviewed published version of this preprint can be found here:

Corrected QT Interval (QTc) Diagnostic App for the Oncological Routine: Development Study

Klier K, Patel Y, Schinköthe T, Harbeck N, Schmidt A

Corrected QT Interval (QTc) Diagnostic App for the Oncological Routine: Development Study

JMIR Cardio 2023;7:e48096

DOI: 10.2196/48096

PMID: 37695655

PMCID: 10520775

Issue in QTc Diagnostic for the Oncological Routine: Method Development

  • Kristina Klier; 
  • Yash Patel; 
  • Timo Schinköthe; 
  • Nadia Harbeck; 
  • Annette Schmidt

ABSTRACT

Background:

Due to cardiotoxic side effects, numerous antineoplastic drugs can cause long QT syndrome (LQTS). When diagnosed by electrocardiogram (ECG) assessments and treated in time, the potentially fatal outcomes of LQTS can be prevented. However, these assessments are associated with patient discomfort and require timely support of the attending oncologist by a cardiologist.

Objective:

This study aimed to examine whether this approach can be made more efficient and comfortable by a smartphone application (QTc Tracker) supporting single-lead ECG records on-site and transferring to a tele-cardiologist for an immediate diagnosis.

Methods:

For evaluation, the QTc Tracker was implemented in 54 cancer centers in Germany. In total, 266 QTc diagnoses of 122 patients were recorded.

Results:

Compared to the routine ECG workflow, the QTc Tracker enabled a substantial turnaround time reduction of 98 % (2.67 hours [1.72 - 2.67 h]) and even further time efficiency in combination with a cardiologic on-call service (12.10 minutes [5.67 - 18.67 min]). Besides, nurses and patients reported higher satisfaction when using the QTc Tracker.

Conclusions:

These results reveal a significant improvement regarding reduced turnaround time and increased user satisfaction. Finally, future studies are needed to empirically test the usability and validity of such mobile ECG assessment methods. Clinical Trial: NCT04055493


 Citation

Please cite as:

Klier K, Patel Y, Schinköthe T, Harbeck N, Schmidt A

Corrected QT Interval (QTc) Diagnostic App for the Oncological Routine: Development Study

JMIR Cardio 2023;7:e48096

DOI: 10.2196/48096

PMID: 37695655

PMCID: 10520775

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.